Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Other Operating Expense : HK$148.7 Mil (TTM As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Other Operating Expense?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2024 was HK$9.8 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was HK$148.7 Mil.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2023 (HK$-84.5 Mil) to Dec. 2023 (HK$147.9 Mil) but then declined from Dec. 2023 (HK$147.9 Mil) to Mar. 2024 (HK$9.8 Mil).

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's annual Other Operating Expense declined from Dec. 2021 (HK$199.1 Mil) to Dec. 2022 (HK$171.2 Mil) and declined from Dec. 2022 (HK$171.2 Mil) to Dec. 2023 (HK$146.0 Mil).

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Other Operating Expense Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

32.19

21.10

199.07

171.18

146.04

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															9.20	75.50	-84.49	147.85	9.80

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$148.7 Mil.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

688505:China

Address

No. 308, Cai Lun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210

Website

http://www.fd-zj.com

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Headlines

No Headlines